IRS Releases Revenue Procedure 2025-28 For Businesses Claiming the R&D Credit Just Before 9/15 and 10/15 Filing Deadlines
- Lindsay Polyak

- Sep 15
- 3 min read

For the past few years, many businesses have been caught off guard by the Tax Cuts and Jobs Act (TCJA) Section 174 rule, which required them to amortize U.S. research and experimentation (R&E) costs over five years. This change blindsided taxpayers claiming the R&D tax credit in 2022 and 2023 and often resulted in higher taxable income and larger tax bills.
In July 2025, the One Big Beautiful Bill created a new Section 174A, restoring the ability for small businesses to fully deduct U.S. R&E expenses. While welcome, the timing raised difficult questions:
How should 2024 tax returns treat R&E expenditures?
What happens to the unamortized balances from 2022 and 2023?
How does all of this coordinate with the R&D credit?
The IRS has now answered these questions in Revenue Procedure 2025-28, issued in late August. This new guidance lays out the rules for elections, superseding returns, and recovering unamortized balances. With the September 15 and October 15th deadlines looming, businesses and their CPAs must evaluate their options.
Key Provisions of IRS Revenue Procedure 2025-28 Impacting 2024 Filings
1. Treatment of Unamortized Section 174 Balances (2022–2024)
Businesses with unamortized R&E costs from TCJA years now have flexibility to:
Deduct the entire remaining balance in 2025, or
Amortize those balances over 2025–2026.
This is handled as an automatic accounting method change on a cut-off basis, meaning no Section 481(a) adjustment is required.
2. Full Deduction on Original 2024 Returns for Small Businesses
Small businesses (≤ $31M in gross receipts) may apply new Section 174A retroactively to 2022–2024.
For 2024, they can deduct all domestic R&E in full on the original return, or elect to amortize over 60+ months.
Important: Making the small business Section 174A election for 2024 will generally require amending 2022 and 2023 returns if those years included amortized R&E expenditures.
3. Six-Month Superseding Return Window
If a 2024 return was timely filed without extension, taxpayers have an automatic six-month window from the original due date (not including extensions) to file a superseding return and make the Section 174A election.
Superseding returns must be clearly marked: “REVENUE PROCEDURE 2025-28.”
4. R&D Credit Coordination and Section 280C
R&E deductions must be reduced by the R&D tax credit unless the taxpayer makes the Section 280C(c)(2) reduced-credit election.
Why this matters: Without the election, the full gross credit is added back into taxable income, cutting the benefit by about the taxpayer’s top rate - 21% for C corporations, often higher for pass-through owners.
Small businesses may still make or revoke this election for 2022–2024 returns via amended or superseding returns until July 6, 2026.
What This Means for 2024 and Beyond
IRS Revenue Procedure 2025-28 creates new options for handling research deductions and credits, including:
Using the superseding return window for 2024,
Deciding whether to accelerate unamortized balances into 2025 or 2025–2026, and
Making (or adjusting) elections for small businesses.
These decisions belong to the business and its CPA, who see the entire tax picture. But the takeaway is clear: every company claiming the R&D credit needs to carefully coordinate Section 174 and Section 280C to maximize value and avoid missteps.
How Tax Credit Collective Helps
At Tax Credit Collective, we don’t make the elections on your return — that’s your CPA’s role. Where we shine is ensuring the R&D credit itself is fully identified, properly calculated, and well-documented.
We deliver bespoke R&D credit studies tailored to your industry and activities, backed by substantiating documentation and audit defense. This gives CPAs confidence that what they file will stand up to IRS scrutiny and ensures you keep more of what you’ve earned.
Every client’s facts and circumstances are unique — and so is every study we deliver. If you want to be certain your R&D credits are optimized, defensible, and coordinated with the latest IRS rules, call us at (214) 414-9881 or request your complimentary consultation.



Comments